Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mock

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
EMBO Molecular Medicine|May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinomaPhilipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Oncotarget|May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patientsAndreas Mock, Rolf Warta, Christoph Geisenberger, et al.
ESMO Open|November 18, 2020
Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trialThomas Walle, Erkin Erdal, Leon Mühlsteffen, et al.
International Journal of Cancer|March 3, 2016
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patientsAndreas Mock, Christoph Geisenberger, Christian Orlik, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Molecular Cancer|March 23, 2025
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancerJiefu Zhou, Min He, Qiong Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
EMBO Molecular Medicine|May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinomaPhilipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Oncotarget|May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patientsAndreas Mock, Rolf Warta, Christoph Geisenberger, et al.
ESMO Open|November 18, 2020
Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trialThomas Walle, Erkin Erdal, Leon Mühlsteffen, et al.
International Journal of Cancer|March 3, 2016
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patientsAndreas Mock, Christoph Geisenberger, Christian Orlik, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Molecular Cancer|March 23, 2025
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancerJiefu Zhou, Min He, Qiong Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
Pageof 7